Therapy codelist - long-acting muscarinic antagonist codes

Name: Therapy codelist - long-acting muscarinic antagonist codes
Creator: London School of Hygiene & Tropical Medicine
Published: 2020-08-01 08:53:59
License: 暂无描述

DataCite Commons2020-08-01 更新2025-04-16 收录

下载链接：

http://datacompass.lshtm.ac.uk/id/eprint/1639

下载链接

链接失效反馈

官方服务：

资源简介：

BNF British National Formulary (BNF) code and drug substance names for long-acting muscarinic antagonists (CPRD).

提供机构：

London School of Hygiene & Tropical Medicine

创建时间：

2020-03-20

Therapy codelist - long-acting beta agonists

British National Formulary (BNF) code and drug substance names for Long-acting Beta-agonist (LABA).

DataCite Commons2020-08-01 更新50

Data for: Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus

EFS-induced contractions in human bronchi of different sizes (Figure S1). Effect of tiotropium on EFS-induced contractions in human bronchi of different sizes (Figure S2).

NIAID Data Ecosystem20

Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review

To review the evidence for the use of open-inhaler (inhaled corticosteroid [ICS] plus long-acting β2-agonist [LABA] with separate add-on long-acting muscarinic antagonist [LAMA]) versus single-inhaler

Mendeley Data2024-06-25 更新60

Data for: Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus

EFS-induced contractions in human bronchi of different sizes (Figure S1). Effect of tiotropium on EFS-induced contractions in human bronchi of different sizes (Figure S2).

Mendeley Data2018-01-19 更新00

Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β 2 -agonist) in asthma patients: a narrative review

To review the evidence for the use of open-inhaler (inhaled corticosteroid [ICS] plus long-acting β 2 -agonist [LABA] with separate add-on long-acting muscarinic antagonist [LAMA]) versus sin

Taylor & Francis Group2023-07-13 更新30